The VISION study will take place at two Golden State Dermatology clinics in Mountain View, California (The Menkes Clinic) and Walnut Creek, California. Golden State Dermatology is a leading and comprehensive dermatology group with 24 locations and over 60 providers.

“Every step in this journey brings us closer to achieving our mission to develop revolutionary imaging technologies for point-of-care digital pathology,” said Gabriel Sanchez, CEO of Enspectra Health. Enspectra’s technology generates digital color images of cellular structure in live skin noninvasively and in real-time.

With real-time evaluation across the surface of the skin, Enspectra’s technology holds the potential to reduce unnecessary biopsies and allow clinicians to examine suspicious lesions earlier. “This technology opens up the possibility for dermatologists to get clear color imaging of suspicious skin lesions without an incision. With this device I see the future…a very exciting future,” said Dr. Andrew Menkes, Dermatologist and Dermatologic Surgeon with Golden State Dermatology.